Bifidobacterium BLa80 mitigates colitis by altering gut microbiota and alleviating inflammation

This study was conducted to explore the therapeutic effect of the probiotic Bifidobacterium animalis subsp. lactis BLa80 on inflammatory bowel disease. A model of ulcerative colitis (UC) was induced in C57BL/6 mice by administering of 2.5% dextran sulphate sodium (DSS) for 8 days. After developing U...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Yao, Liao, Wenyan, Tang, Jing, Fei, Teng, Gai, Zhonghui, Han, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174416/
https://www.ncbi.nlm.nih.gov/pubmed/35670877
http://dx.doi.org/10.1186/s13568-022-01411-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174416/
https://www.ncbi.nlm.nih.gov/pubmed/35670877
http://dx.doi.org/10.1186/s13568-022-01411-z

Ejemplares similares